The Effect of Eyeliner on Tear Composition, Tear Secretion and Tear Film Stability.
NCT05632887 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 80
Last updated 2025-09-29
Summary
Eyeliner is one of the most common eye cosmetics. The main ingredients are titanium oxide, pigment, grease and preservative. The user will apply the eyeliner to the eyelid and eyelash. With the blinking again and again, the components of the eyeliner may enter the tear film and continue to act on the eye surface. Therefore, the investigators suspect that the use of eyeliner may be an important factor leading to dry eye disease. In order to explore the relationship between the use of eyeliner and dry eye disease, the investigators plan to collect eye surface characteristic data of the two groups of people who use eyeliner and who do not use it.Then use Raman analysis to explore whether the use of eyeliner will lead to changes in tear composition.The investigators intend to analyze the difference of tear composition between the two groups to understand the relationship between the change of tear composition and tear film stability.So that the investigators can identify the risk factors of dry eye disease, and provide basis for prevention and early treatment.
Conditions
- Dry Eye
Interventions
- OTHER
-
no intervention
no intervention
Sponsors & Collaborators
-
Zhongnan Hospital
lead OTHER
Principal Investigators
-
Min Ke · Ophthalmology Department of Zhongnan Hospital of Wuhan University
Eligibility
- Min Age
- 20 Years
- Max Age
- 35 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-11-20
- Primary Completion
- 2026-09-15
- Completion
- 2026-09-30
Countries
- China
Study Locations
More Related Trials
-
A Clinical Evaluation Pilot Study of the Efficacy of Blink® Tears Lubricant Eye Drops for the Relief of Dry Eye Symptoms Following Implantation of Tecnis® Multifocal Introcular Lens
NCT01061268 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Manuka Eye Drops on Tear Film Properties
NCT03622619 ·Status: COMPLETED ·Phase: NA
-
Phase III Confirmatory Study of DE-089 Ophthalmic Solution in Patients With Dry Eye
NCT01240382 ·Status: COMPLETED ·Phase: PHASE3
-
Metabolites of Tear Fluid
NCT03389282 ·Status: UNKNOWN
-
Tear Lipid Layer Thickness Assessments With Perfluorohexyloctane Eye Drops
NCT05288582 ·Status: COMPLETED ·Phase: NA
-
A Study To Investigate The Effects Of A Low Humidity Environment And Visual Tasking On Tear Film Protein Composition
NCT02005874 ·Status: COMPLETED
-
Efficacy and Safety of SHR8028 Eye Drops for the Treatment of Dry Eye Disease
NCT05841043 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Blink Tears and Systane Concomitant With Restasis for the Treatment of Dry Eye Symptoms
NCT00565669 ·Status: COMPLETED ·Phase: NA
-
Changes in Tear Lipid Layer Thickness After Short Exposure to Light Emitting Diode Displays
NCT05003128 ·Status: COMPLETED ·Phase: NA
-
Dry Eye Under China's Dynamic COVID-zero Strategy
NCT05476068 ·Status: COMPLETED
-
Mask-associated Dry Eye Symptoms in China
NCT04744805 ·Status: UNKNOWN
-
Safety and Efficacy Study of New Eye Drop Formulations With Refresh Tears® in Patients With Dry Eye Disease
NCT01294384 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of 0.05% CsA Eye Drops on Diabetic Patients with Dry Eye Disease
NCT06824844 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of 0.28% Sodium Hyaluronate Eye Drops in Patient with Moderate to Severe Dry Eye
NCT06860659 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4
-
A Study to Determine the Relief of Dry Eye Symptoms With the Use of TheraTears® Products (DUNLIN)
NCT02014922 ·Status: COMPLETED ·Phase: PHASE4
-
A Clinical Trial to Evaluate the Effects of an Eye Serum on Improving the Appearance of the Periorbital Area
NCT06143033 ·Status: COMPLETED ·Phase: NA
-
Wireless Micropump in Dry Eye Patients
NCT04667819 ·Status: UNKNOWN ·Phase: NA
-
Efficacy of the Chronic Application of Tear Formulations
NCT01384851 ·Status: UNKNOWN ·Phase: NA
-
Efficacy of Nonsteroidal Anti-inflammatory Drugs in Treatment of Moderate and Severe Dry Eye Disease
NCT01562795 ·Status: COMPLETED ·Phase: NA
-
Effect of Traditional Chinese Medicine on Basic Tear Secretion and Tear Cytokines in Patients With Dry Eye Disease
NCT04785261 ·Status: UNKNOWN ·Phase: PHASE2
-
Effect of Topical Naltrexone Ophthalmic Solution on the Signs and Symptoms of Dry Eye in Diabetic Subjects
NCT03660475 ·Status: COMPLETED ·Phase: PHASE2
-
Investigation on Medical Management of Dry Eye Patients
NCT01942226 ·Status: COMPLETED
-
Tear Osmolarity Changes After Instilling Isotonic Hyaluronate Artificial Tears
NCT01614847 ·Status: COMPLETED ·Phase: PHASE4
-
Dry Eye Symptoms and Quality of Life
NCT01988597 ·Status: COMPLETED
-
Prevalence of Dry Eyes in Diabetics Compared to Non Diabetics
NCT01450787 ·Status: TERMINATED